Items where Subject is "Hematology"
  • ASJC Scopus Subject Areas (4053)
  • Medicine(all) (890)
  • Hematology (17)
    Number of items at this level: 17.
    A
  • Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019) Krishma Adatia, Mohamed Farag, Ying X. Gue, Manivannan Srinivasan and Diana Gorog
  • B
  • Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. (2023) Geoffrey D Barnes, Walter Ageno, Lana A Castellucci, Thita Chiasakul, Renee Eslick, Jose Luis Ferreiro, David Gailani, Diana Gorog, Gregory Y H Lip, Leslie Raffini, Suely M Rezende, Jeffrey I Weitz and Adam Cuker
  • C
  • Erdafitinib in BCG-treated high risk non-muscle invasive bladder cancer. (2024) James W.F. Catto, Ben Tran, Morgan Roupret, Juergen E. Gschwend, Yohann Loriot, Hiroyuki Nishiyama, Joan P. Redorta, Siamak Daneshmand, Syed A. Hussain, Hernan J Cutuli, Giuseppe Procopio, Valentina Guadalupi, Nikhil Vasdev, Vahid Naini, Lauren Crow, Spyros Triantos, Mahadi Baig and Gary D. Steinberg
  • D
  • Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores. (2018) Andrew Davenport, Ayman Guirguis, Michael Almond, Clara Day, Joseph Chilcot, Maria Da Silva Gane, Naomi Fineberg, Karin Friedl, Benjamin Spencer, David Wellsted and Ken Farrington
  • F
  • Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size. (2018) Mohamed Farag, Nikolaos Spinthakis, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A Gorog
  • G
  • Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice. (2019) Tobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, Karin L. Mueller, Dominik Rath, Michal Droppa, Juergen Schreieck, Peter Seizer, Robert F. Storey, Steen D. Kristensen, Andrea Rubboli, Diana Gorog, Daniel Aradi, Dirk Sibbing, Kurt Huber, Meinrad Gawaz and Jur Ten Berg
  • Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023) Diana Gorog, Visvesh Jeyalan, Rafaella I. L. Markides, Eliano P Navarese, Young-Hoon Jeong and Mohamed Farag
  • Haematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instruments. (2019) Pushpendra Goswami, Yasmin Khatib and Sam Salek
  • The Burden of Disease in Pyruvate Kinase Deficiency: Patients' Perception of the Impact on Health-Related Quality of Life. (2018) RF Grace, L Cohen, S Egan, T Wells, B Witherspoon, A Ryan, Mir-Saeed Shayegan Salek, S Bodie and RJ Klaassen
  • MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort. (2019) Ying X. Gue, Natasha Corballis, Alisdair Ryding, Juan Carlos Kaski and Diana Gorog
  • Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024) Ying X. Gue, Vassilios Memtsas, Rahim Kanji, David Wellsted, Amanda Busby, Megan Smith, Enric Vilar, Alisdair Ryding, Deepa J. Arachchillage and Diana Gorog
  • Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. (2019) Ying X Gue, Rahim Kanji, David M Wellsted, Manivannan Srinivasan, Solange Wyatt and Diana A Gorog
  • K
  • Measuring thrombus stability at high shear, together with thrombus formation and endogenous fibrinolysis: first experience using the Global Thrombosis Test 3 (GTT-3). (2023) Rahim Kanji, Joshua Leader, Vassilios Memtsas and Diana Gorog
  • Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients. (2020) Nazish Khan, Mamas A. Mamas, Alexandra Moss, Diana A. Gorog, Peter Nightingale, Angel Armesilla, Andrew Smallwood, Shahzad Munir, Saib Khogali, Ben Wrigley and James M. Cotton
  • The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. (2020) Hyun Kuk Kim, Udaya S. Tantry, Sidney C. Smith, Myung Ho Jeong, Seung Jung Park, Moo Hyun Kim, Do Sun Lim, Eun Seok Shin, Duk Woo Park, Yong Huo, Shao Liang Chen, Zheng Bo, Shinya Goto, Takeshi Kimura, Satoshi Yasuda, Wen Jone Chen, Mark Chan, Daniel Aradi, Tobias Geisler, Diana A. Gorog, Dirk Sibbing, Gregory Y.H. Lip, Dominick J. Angiolillo, Paul A. Gurbel and Young Hoon Jeong
  • L
  • C2 by-pass: Cross-talk between the complement classical and alternative pathways. (2022) A Laich, H Patel, A Zarantonello, R B Sim and J M Inal
  • S
  • Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. (2019) Nikolaos Spinthakis, Ying Gue, Mohamed Farag, Guogang Ren, Manivannan Srinivasan, Anwar Baydoun and Diana A Gorog